• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻常型银屑病患者的严重程度与治疗方法与 C-反应蛋白和白细胞活化的关系。

C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.

机构信息

Faculdade de Farmácia, Serviço de Bioquímica, Universidade do Porto, Porto, Portugal.

出版信息

J Eur Acad Dermatol Venereol. 2010 Jul;24(7):789-96. doi: 10.1111/j.1468-3083.2009.03527.x. Epub 2009 Dec 11.

DOI:10.1111/j.1468-3083.2009.03527.x
PMID:20002653
Abstract

BACKGROUND

Psoriasis vulgaris is a chronic recurrent inflammatory skin disease and psoriatic lesions have shown leucocyte infiltration.

OBJECTIVES

We aimed to study C-reactive protein (CRP) and leucocyte activation markers/inhibitors as potential monitors of psoriasis vulgaris.

METHODS

A cross-sectional (n = 73) and a longitudinal study (before, at 3, 6 and 12 weeks of therapy; n = 47) was performed; 10 patients started topical treatment, 17 narrow-band ultraviolet light B (NBUVB) and 20 psolaren associated to UVA (PUVA); psoriasis severity was defined by Psoriasis Area and Severity Index (PASI).

RESULTS

Compared with control (n = 38), we found higher CRP levels, total leukocyte/neutrophil count, elastase, lactoferrin and alpha1-antitrypsin. Increasing PASI was linked to increasing CRP and a trend to higher elastase and lactoferrin, suggesting that worsening enhances inflammatory response with neutrophil activation. CRP correlated with PASI, total leucocytes, neutrophils, elastase, lactoferrin and alpha1-antitrypsin. NBUVB and PUVA presented similar effects.

CONCLUSION

We propose CRP as a useful marker of psoriasis severity that could be used to monitor psoriasis and its treatment, and, together with PASI and elastase, could also be used as a global index of severity.

摘要

背景

寻常型银屑病是一种慢性复发性炎症性皮肤病,银屑病皮损有白细胞浸润。

目的

我们旨在研究 C 反应蛋白(CRP)和白细胞激活标志物/抑制剂作为寻常型银屑病潜在的监测指标。

方法

进行了横断面(n = 73)和纵向研究(治疗前、3、6 和 12 周时;n = 47);10 例患者开始接受局部治疗,17 例接受窄带紫外线 B(NBUVB)治疗,20 例接受光化学疗法(PUVA);银屑病严重程度用银屑病面积和严重程度指数(PASI)来定义。

结果

与对照组(n = 38)相比,我们发现 CRP 水平、总白细胞/中性粒细胞计数、弹性蛋白酶、乳铁蛋白和α1-抗胰蛋白酶较高。PASI 增加与 CRP 增加以及弹性蛋白酶和乳铁蛋白增加呈正相关,表明病情恶化会增强炎症反应和中性粒细胞的激活。CRP 与 PASI、总白细胞、中性粒细胞、弹性蛋白酶、乳铁蛋白和α1-抗胰蛋白酶相关。NBUVB 和 PUVA 有相似的效果。

结论

我们提出 CRP 是一种有用的银屑病严重程度标志物,可用于监测银屑病及其治疗,与 PASI 和弹性蛋白酶一起,也可作为严重程度的综合指标。

相似文献

1
C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.寻常型银屑病患者的严重程度与治疗方法与 C-反应蛋白和白细胞活化的关系。
J Eur Acad Dermatol Venereol. 2010 Jul;24(7):789-96. doi: 10.1111/j.1468-3083.2009.03527.x. Epub 2009 Dec 11.
2
The inflammatory response in mild and in severe psoriasis.轻度和重度银屑病中的炎症反应。
Br J Dermatol. 2004 May;150(5):917-28. doi: 10.1111/j.1365-2133.2004.05984.x.
3
Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.葡萄牙寻常型银屑病患者治疗前后的红细胞紊乱:一项横断面和纵向研究。
Am J Clin Dermatol. 2012 Feb 1;13(1):37-47. doi: 10.2165/11592110-000000000-00000.
4
Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.银屑病治疗与心血管危险因素:一项为期 12 周的随访研究。
Am J Clin Dermatol. 2010 Dec 1;11(6):423-32. doi: 10.2165/11319310-000000000-00000.
5
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.依那西普对银屑病及银屑病关节炎患者C反应蛋白水平的影响。
Br J Dermatol. 2008 Aug;159(2):322-30. doi: 10.1111/j.1365-2133.2008.08628.x. Epub 2008 May 22.
6
The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.炎症标志物在评估接受依那西普治疗的银屑病患者疾病严重程度和治疗反应中的作用。
Clin Exp Dermatol. 2011 Dec;36(8):845-50. doi: 10.1111/j.1365-2230.2011.04131.x. Epub 2011 Jul 25.
7
Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.窄谱中波紫外线治疗银屑病期间补充硒、可溶性肿瘤坏死因子-α受体1型及C反应蛋白
Nutrition. 2006 Sep;22(9):860-4. doi: 10.1016/j.nut.2006.05.011. Epub 2006 Jul 10.
8
Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.寻常型银屑病患者经外用、NB-UVB 和 PUVA 治疗后缓解期长短的主要决定因素:一项随访研究。
Am J Clin Dermatol. 2013 Feb;14(1):49-53. doi: 10.1007/s40257-012-0002-8.
9
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.炎症性肠病中肠道炎症评估的非侵入性标志物:粪便乳铁蛋白、钙卫蛋白、PMN弹性蛋白酶、CRP及临床指标的表现
Am J Gastroenterol. 2008 Jan;103(1):162-9. doi: 10.1111/j.1572-0241.2007.01556.x. Epub 2007 Oct 4.
10
Evaluation of soluble CD163 as a marker of inflammation in psoriasis.评价可溶性 CD163 在银屑病炎症反应中的标志物作用。
Clin Exp Dermatol. 2011 Mar;36(2):201-3. doi: 10.1111/j.1365-2230.2010.03949.x. Epub 2010 Nov 10.

引用本文的文献

1
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.瘦素:一种与性别和肥胖相关的标志物,可预测银屑病患者的代谢合并症及对抗白细胞介素-23生物药物的治疗反应。
Front Immunol. 2025 Jul 16;16:1607312. doi: 10.3389/fimmu.2025.1607312. eCollection 2025.
2
From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP.从稳态到炎症再到自身免疫:C反应蛋白的潜在影响。
Inflammation. 2025 Jul 18. doi: 10.1007/s10753-025-02303-7.
3
Clinicopathological features and renal outcomes in patients with IgA nephropathy secondary to psoriasis.
银屑病继发IgA肾病患者的临床病理特征及肾脏预后
Clin Exp Med. 2025 Jun 17;25(1):207. doi: 10.1007/s10238-025-01750-8.
4
The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis.银屑病患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及全身免疫炎症指数标志物与生物治疗反应的关系
Int J Mol Sci. 2025 Apr 19;26(8):3868. doi: 10.3390/ijms26083868.
5
Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis.生物制剂对银屑病患者血脂谱和血常规参数的影响。
Arch Dermatol Res. 2025 Apr 10;317(1):692. doi: 10.1007/s00403-025-04192-0.
6
Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study.银屑病治疗与生物制剂转换:一项为期13年的回顾性研究中与临床特征和实验室生物标志物的关联
J Dermatol. 2024 Dec;51(12):1572-1578. doi: 10.1111/1346-8138.17465. Epub 2024 Sep 13.
7
The Association Between Psoriasis and Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies.银屑病与动脉粥样硬化性心血管疾病之间的关联:观察性研究的系统评价和荟萃分析
Cureus. 2024 Jun 28;16(6):e63379. doi: 10.7759/cureus.63379. eCollection 2024 Jun.
8
Platelet Reactivity in the Exacerbation of Psoriasis.银屑病加重期的血小板反应性
J Clin Med. 2024 Feb 8;13(4):965. doi: 10.3390/jcm13040965.
9
Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies.系统性抗银屑病治疗会影响心血管疾病风险吗?心血管成像研究综述
Dermatol Ther (Heidelb). 2024 Feb;14(2):303-321. doi: 10.1007/s13555-024-01098-z. Epub 2024 Jan 30.
10
Prevalence of metabolic syndrome and chronic inflammation in psoriasis before and after biologic therapy: a prospective study.生物治疗前后银屑病患者代谢综合征和慢性炎症的患病率:一项前瞻性研究。
Med Pharm Rep. 2023 Oct;96(4):368-383. doi: 10.15386/mpr-2631. Epub 2023 Oct 26.